Industry: Medical Devices & Consumables
Published Date: 2024-07-27
Pages: 185 Pages
Report ld: 3259501
Request Sample
Customized Report
The global Poultry Viral Disease Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
The US & Canada market for Poultry Viral Disease Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The China market for Poultry Viral Disease Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The Europe market for Poultry Viral Disease Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key manufacturers of Poultry Viral Disease Vaccines include Merck, Boehringer Ingelheim, Ceva, Zoetis, Vaxxinova®, Elanco, QYH Biotech Co., Ltd, Pulike, Phibro Animal Health Corporation, JinYu Biotechnology, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Poultry Viral Disease Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Poultry Viral Disease Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Poultry Viral Disease Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Poultry Viral Disease Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Poultry Viral Disease Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Poultry Viral Disease Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Boehringer Ingelheim, Ceva, Zoetis, Vaxxinova®, Elanco, QYH Biotech Co., Ltd, Pulike, Phibro Animal Health Corporation, JinYu Biotechnology, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Poultry Viral Disease Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Poultry Viral Disease Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Poultry Viral Disease Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Poultry Viral Disease Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Poultry Viral Disease Vaccines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Live
1.2.3 Attenuated
1.2.4 Killed
1.3 Market by Application
1.3.1 Global Poultry Viral Disease Vaccines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 NDV
1.3.3 Marek ' s Disease
1.3.4 IBD
1.3.5 Infectious Bronchitis
1.3.6 Influenza
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Poultry Viral Disease Vaccines Revenue Estimates and Forecasts 2019-2030
2.2 Global Poultry Viral Disease Vaccines Revenue by Region
2.2.1 Global Poultry Viral Disease Vaccines Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Poultry Viral Disease Vaccines Revenue by Region (2019-2024)
2.2.3 Global Poultry Viral Disease Vaccines Revenue by Region (2025-2030)
2.2.4 Global Poultry Viral Disease Vaccines Revenue Market Share by Region (2019-2030)
2.3 Global Poultry Viral Disease Vaccines Sales Estimates and Forecasts 2019-2030
2.4 Global Poultry Viral Disease Vaccines Sales by Region
2.4.1 Global Poultry Viral Disease Vaccines Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Poultry Viral Disease Vaccines Sales by Region (2019-2024)
2.4.3 Global Poultry Viral Disease Vaccines Sales by Region (2025-2030)
2.4.4 Global Poultry Viral Disease Vaccines Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Poultry Viral Disease Vaccines Sales by Manufacturers
3.1.1 Global Poultry Viral Disease Vaccines Sales by Manufacturers (2019-2024)
3.1.2 Global Poultry Viral Disease Vaccines Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Poultry Viral Disease Vaccines in 2023
3.2 Global Poultry Viral Disease Vaccines Revenue by Manufacturers
3.2.1 Global Poultry Viral Disease Vaccines Revenue by Manufacturers (2019-2024)
3.2.2 Global Poultry Viral Disease Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Poultry Viral Disease Vaccines Revenue in 2023
3.3 Global Key Players of Poultry Viral Disease Vaccines, Industry Ranking, 2021 VS 2022
3.4 Global Poultry Viral Disease Vaccines Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Poultry Viral Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Poultry Viral Disease Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Poultry Viral Disease Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Poultry Viral Disease Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Poultry Viral Disease Vaccines Sales by Type
4.1.1 Global Poultry Viral Disease Vaccines Historical Sales by Type (2019-2024)
4.1.2 Global Poultry Viral Disease Vaccines Forecasted Sales by Type (2025-2030)
4.1.3 Global Poultry Viral Disease Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Poultry Viral Disease Vaccines Revenue by Type
4.2.1 Global Poultry Viral Disease Vaccines Historical Revenue by Type (2019-2024)
4.2.2 Global Poultry Viral Disease Vaccines Forecasted Revenue by Type (2025-2030)
4.2.3 Global Poultry Viral Disease Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Poultry Viral Disease Vaccines Price by Type
4.3.1 Global Poultry Viral Disease Vaccines Price by Type (2019-2024)
4.3.2 Global Poultry Viral Disease Vaccines Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Poultry Viral Disease Vaccines Sales by Application
5.1.1 Global Poultry Viral Disease Vaccines Historical Sales by Application (2019-2024)
5.1.2 Global Poultry Viral Disease Vaccines Forecasted Sales by Application (2025-2030)
5.1.3 Global Poultry Viral Disease Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Poultry Viral Disease Vaccines Revenue by Application
5.2.1 Global Poultry Viral Disease Vaccines Historical Revenue by Application (2019-2024)
5.2.2 Global Poultry Viral Disease Vaccines Forecasted Revenue by Application (2025-2030)
5.2.3 Global Poultry Viral Disease Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Poultry Viral Disease Vaccines Price by Application
5.3.1 Global Poultry Viral Disease Vaccines Price by Application (2019-2024)
5.3.2 Global Poultry Viral Disease Vaccines Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Poultry Viral Disease Vaccines Market Size by Type
6.1.1 US & Canada Poultry Viral Disease Vaccines Sales by Type (2019-2030)
6.1.2 US & Canada Poultry Viral Disease Vaccines Revenue by Type (2019-2030)
6.2 US & Canada Poultry Viral Disease Vaccines Market Size by Application
6.2.1 US & Canada Poultry Viral Disease Vaccines Sales by Application (2019-2030)
6.2.2 US & Canada Poultry Viral Disease Vaccines Revenue by Application (2019-2030)
6.3 US & Canada Poultry Viral Disease Vaccines Market Size by Country
6.3.1 US & Canada Poultry Viral Disease Vaccines Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Poultry Viral Disease Vaccines Revenue by Country (2019-2030)
6.3.3 US & Canada Poultry Viral Disease Vaccines Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Poultry Viral Disease Vaccines Market Size by Type
7.1.1 Europe Poultry Viral Disease Vaccines Sales by Type (2019-2030)
7.1.2 Europe Poultry Viral Disease Vaccines Revenue by Type (2019-2030)
7.2 Europe Poultry Viral Disease Vaccines Market Size by Application
7.2.1 Europe Poultry Viral Disease Vaccines Sales by Application (2019-2030)
7.2.2 Europe Poultry Viral Disease Vaccines Revenue by Application (2019-2030)
7.3 Europe Poultry Viral Disease Vaccines Market Size by Country
7.3.1 Europe Poultry Viral Disease Vaccines Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Poultry Viral Disease Vaccines Revenue by Country (2019-2030)
7.3.3 Europe Poultry Viral Disease Vaccines Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Poultry Viral Disease Vaccines Market Size by Type
8.1.1 China Poultry Viral Disease Vaccines Sales by Type (2019-2030)
8.1.2 China Poultry Viral Disease Vaccines Revenue by Type (2019-2030)
8.2 China Poultry Viral Disease Vaccines Market Size by Application
8.2.1 China Poultry Viral Disease Vaccines Sales by Application (2019-2030)
8.2.2 China Poultry Viral Disease Vaccines Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Poultry Viral Disease Vaccines Market Size by Type
9.1.1 Asia Poultry Viral Disease Vaccines Sales by Type (2019-2030)
9.1.2 Asia Poultry Viral Disease Vaccines Revenue by Type (2019-2030)
9.2 Asia Poultry Viral Disease Vaccines Market Size by Application
9.2.1 Asia Poultry Viral Disease Vaccines Sales by Application (2019-2030)
9.2.2 Asia Poultry Viral Disease Vaccines Revenue by Application (2019-2030)
9.3 Asia Poultry Viral Disease Vaccines Market Size by Region
9.3.1 Asia Poultry Viral Disease Vaccines Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Poultry Viral Disease Vaccines Revenue by Region (2019-2030)
9.3.3 Asia Poultry Viral Disease Vaccines Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Market Size by Country
10.3.1 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Poultry Viral Disease Vaccines Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Information
11.2.2 Boehringer Ingelheim Overview
11.2.3 Boehringer Ingelheim Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Boehringer Ingelheim Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Ceva
11.3.1 Ceva Company Information
11.3.2 Ceva Overview
11.3.3 Ceva Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Ceva Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Ceva Recent Developments
11.4 Zoetis
11.4.1 Zoetis Company Information
11.4.2 Zoetis Overview
11.4.3 Zoetis Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Zoetis Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zoetis Recent Developments
11.5 Vaxxinova®
11.5.1 Vaxxinova® Company Information
11.5.2 Vaxxinova® Overview
11.5.3 Vaxxinova® Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Vaxxinova® Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Vaxxinova® Recent Developments
11.6 Elanco
11.6.1 Elanco Company Information
11.6.2 Elanco Overview
11.6.3 Elanco Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Elanco Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Elanco Recent Developments
11.7 QYH Biotech Co., Ltd
11.7.1 QYH Biotech Co., Ltd Company Information
11.7.2 QYH Biotech Co., Ltd Overview
11.7.3 QYH Biotech Co., Ltd Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 QYH Biotech Co., Ltd Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 QYH Biotech Co., Ltd Recent Developments
11.8 Pulike
11.8.1 Pulike Company Information
11.8.2 Pulike Overview
11.8.3 Pulike Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Pulike Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pulike Recent Developments
11.9 Phibro Animal Health Corporation
11.9.1 Phibro Animal Health Corporation Company Information
11.9.2 Phibro Animal Health Corporation Overview
11.9.3 Phibro Animal Health Corporation Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Phibro Animal Health Corporation Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Phibro Animal Health Corporation Recent Developments
11.10 JinYu Biotechnology
11.10.1 JinYu Biotechnology Company Information
11.10.2 JinYu Biotechnology Overview
11.10.3 JinYu Biotechnology Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 JinYu Biotechnology Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 JinYu Biotechnology Recent Developments
11.11 Harbin Pharmaceutical Group
11.11.1 Harbin Pharmaceutical Group Company Information
11.11.2 Harbin Pharmaceutical Group Overview
11.11.3 Harbin Pharmaceutical Group Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Harbin Pharmaceutical Group Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Harbin Pharmaceutical Group Recent Developments
11.12 MEVAC
11.12.1 MEVAC Company Information
11.12.2 MEVAC Overview
11.12.3 MEVAC Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 MEVAC Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 MEVAC Recent Developments
11.13 Venky's
11.13.1 Venky's Company Information
11.13.2 Venky's Overview
11.13.3 Venky's Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Venky's Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Venky's Recent Developments
11.14 Japfa Comfeed Indonesia
11.14.1 Japfa Comfeed Indonesia Company Information
11.14.2 Japfa Comfeed Indonesia Overview
11.14.3 Japfa Comfeed Indonesia Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Japfa Comfeed Indonesia Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Japfa Comfeed Indonesia Recent Developments
11.15 Nisseiken
11.15.1 Nisseiken Company Information
11.15.2 Nisseiken Overview
11.15.3 Nisseiken Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Nisseiken Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nisseiken Recent Developments
11.16 Hile
11.16.1 Hile Company Information
11.16.2 Hile Overview
11.16.3 Hile Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Hile Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Hile Recent Developments
11.17 Hester Biosciences
11.17.1 Hester Biosciences Company Information
11.17.2 Hester Biosciences Overview
11.17.3 Hester Biosciences Poultry Viral Disease Vaccines Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Hester Biosciences Poultry Viral Disease Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Hester Biosciences Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Poultry Viral Disease Vaccines Industry Chain Analysis
12.2 Poultry Viral Disease Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Poultry Viral Disease Vaccines Production Mode & Process
12.4 Poultry Viral Disease Vaccines Sales and Marketing
12.4.1 Poultry Viral Disease Vaccines Sales Channels
12.4.2 Poultry Viral Disease Vaccines Distributors
12.5 Poultry Viral Disease Vaccines Customers
13 Poultry Viral Disease Vaccines Market Dynamics
13.1 Poultry Viral Disease Vaccines Industry Trends
13.2 Poultry Viral Disease Vaccines Market Drivers
13.3 Poultry Viral Disease Vaccines Market Challenges
13.4 Poultry Viral Disease Vaccines Market Restraints
14 Key Findings in the Global Poultry Viral Disease Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Poultry Viral Disease Vaccines market is projected to grow from US$ 2140 million in 2025 to US$ 3392 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-04-04
Pages: 177
USD 4900.00
(Single User License)
The global Poultry Viral Disease Vaccines market size was US$ 2140 million in 2025 and is forecast to reach a readjusted size of US$ 3392 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published Date: 2026-04-04
Pages: 110
USD 4250.00
(Single User License)
The global market for Poultry Viral Disease Vaccines was estimated to be worth US$ 2140 million in 2025 and is projected to reach US$ 3392 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-04-04
Pages: 143
USD 3950.00
(Single User License)
The global Poultry Viral Disease Vaccines market was valued at US$ 2140 million in 2025 and is anticipated to reach US$ 3392 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-04-04
Pages: 129
USD 2900.00
(Single User License)
The global Poultry Viral Disease Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 174
USD 4900.00
(Single User License)
The global Poultry Viral Disease Vaccines market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 103
USD 4250.00
(Single User License)
The global market for Poultry Viral Disease Vaccines was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 131
USD 3950.00
(Single User License)
The global market for Poultry Viral Disease Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 102
USD 2900.00
(Single User License)
The global Poultry Viral Disease Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-07-27
Pages: 106
USD 2900.00
(Single User License)
The global Poultry Viral Disease Vaccines revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-07-27
Pages: 145
USD 4350.00
(Single User License)
The global Poultry Viral Disease Vaccines market is projected to grow from US$ 2140 million in 2025 to US$ 3392 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-04-04
Pages: 177
The global Poultry Viral Disease Vaccines market size was US$ 2140 million in 2025 and is forecast to reach a readjusted size of US$ 3392 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-04-04
Pages: 110
The global market for Poultry Viral Disease Vaccines was estimated to be worth US$ 2140 million in 2025 and is projected to reach US$ 3392 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-04-04
Pages: 143
The global Poultry Viral Disease Vaccines market was valued at US$ 2140 million in 2025 and is anticipated to reach US$ 3392 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-04-04
Pages: 129
The global Poultry Viral Disease Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 174
The global Poultry Viral Disease Vaccines market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 103
The global market for Poultry Viral Disease Vaccines was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 131
The global market for Poultry Viral Disease Vaccines was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 102
The global Poultry Viral Disease Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-07-27
Pages: 106
The global Poultry Viral Disease Vaccines revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-07-27
Pages: 145
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now